Hanseatic Management Services Inc Bluebird Bio, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $233,168 - $308,293	-2,624 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $26,603 - $34,066	267 Added 11.33%	2,624 $412,000
Q1 2018 May 02, 2018	BUY	$105.8 - $150.94 $2,433 - $3,471	23 Added 0.99%	2,357 $402,000
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $24,212 - $38,948	298 Added 14.64%	2,334 $416,000
Q3 2017 Nov 07, 2017	SELL	$57.74 - $91.42 $485,016 - $767,928	-8,400 Reduced 80.49%	2,036 $280,000
Q2 2017 Aug 11, 2017	BUY	N/A	10,436	10,436 $1.1 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.